ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.16
-0.57%
US Tech 100
18,174.80
0.00%
S&P 500
5,291.34
0.15%
US Dollar vs CAD
1.36744
-0.02%
Bitcoin
71,132.33
0.72%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/05/20242:50AMPR Newswire (US)Reusable Water Bottle Market to Reach $13,549.0 Million, Globally, by 2032 at 4.5% CAGR: Allied Market Research
06/05/20242:30AMPR Newswire (US)Resolution Therapeutics Announces New Breakthrough Clinical Data for Macrophage Cell Therapy in End Stage Liver Disease at EASL 2024
06/05/20242:30AMPR Newswire (US)Resolution Therapeutics Announces New Breakthrough Clinical Data for Macrophage Cell Therapy in End Stage Liver Disease at EASL 2024
06/05/20242:16AMPR Newswire (US)Smartphone Photo Printers Market to Reach $37.0 Billion Globally by 2032 at 7.1% CAGR: Allied Market Research
06/05/20242:15AMPR Newswire (US)Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations
06/05/20242:15AMPR Newswire (US)Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations
06/05/20242:15AMPR Newswire (Canada)Pierre Fabre Laboratories Announce IND Filing for PFL-002/VERT-002, a Potential Treatment for Patients with Solid Tumors, Including Non-Small Cell Lung Cancer with MET Alterations
06/05/20242:11AMPR Newswire (US)Smartphone Photo Printers Market to Reach $37.0 Billion Globally by 2032 at 7.1% CAGR: Allied Market Research
06/05/20242:00AMPR Newswire (US)Northern Data Group to showcase Generative AI platform at HPE Discover 2024
06/05/20242:00AMPR Newswire (US)Dream Vacations Launches LGBTQ+ Marketing and Training Resources for Pride Month and Beyond
06/05/20242:00AMPR Newswire (US)Altius Aviation Successfully Achieves FAA SMS Part 5 Acceptance with Expert Guidance from Aviation Safety Solutions
06/05/20242:00AMPR Newswire (US)Former Head of Risk at Hedge Fund's RAM and EIM joins fintech Premialab
06/05/20242:00AMPR Newswire (US)Runergy to Showcase its Newest PV Modules at Intersolar Europe 2024
06/05/20242:00AMPR Newswire (US)Al Gore Drives Climate Hysteria at WHO - Canada's Contentious Carbon Tax on the Verge of Collapse says Friends of Science Society
06/05/20242:00AMPR Newswire (US)Unitek College Recognized at the 25th Northern Nevada Nurses of Achievement Awards Dinner
06/05/20242:00AMPR Newswire (US)Newest ezACH Direct Deposit Software Processes Quarterly Payment Transactions To the Government
06/05/20241:48AMPR Newswire (US)China Surpasses USA and Becomes Largest Trading Partner of India in FY24 - Volza
06/05/20241:48AMPR Newswire (US)Sectra's year-end report 2023/2024: Cloud recurring revenue up more than 50%--unchanged dividend proposed
06/05/20241:45AMPR Newswire (US)Sectra's year-end report 2023/2024: Cloud recurring revenue up more than 50%--unchanged dividend proposed
06/05/20241:41AMPR Newswire (US)Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series
06/05/20241:32AMPR Newswire (US)For Germany's He Chen, capital is an amazing place
06/05/20241:30AMPR Newswire (US)Virion Therapeutics Reports Positive First-in-human, First-in-class, Phase 1b Immunogenicity Data of VRON-0200, a Novel Checkpoint Modifier for HBV Functional Cure at EASL Congress
06/05/20241:28AMPR Newswire (US)Capitainer Enters African Market through Strategic Partnership with Lasec®
06/05/20241:08AMPR Newswire (Canada)Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series
06/05/20241:08AMPR Newswire (US)Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series
06/05/20241:00AMPR Newswire (US)ExoAnalytic Solutions Announces Planned Acquisition of UK Startup 3S Northumbria
06/05/20241:00AMPR Newswire (US)Remote and Nium Join Forces to Power Global Workforces with Real-time Cross-border Payments
06/05/20241:00AMPR Newswire (US)GC Genome Highlights Promising New Approach for Non-invasive Colorectal Cancer Detection at ASCO 2024
06/05/20241:00AMPR Newswire (US)ExoAnalytic Solutions Announces Planned Acquisition of UK Startup 3S Northumbria
06/05/20241:00AMPR Newswire (US)RepRisk launches industry-first thematic Due Diligence Scores to streamline business conduct risk monitoring

Your Recent History

NYSE
PV
Primavera Capital Acquis...
BIT
P1U1Q1
NLBNPIT1U1Q1 20241220 15
COIN
TLOSUST
Telos
UNSW3
ROOMETH
OptionRoom Token
COIN
FACEUSD
BIT
S32131
Societe Generale Effekten
BIT
P1ZCX6
NLBNPIT1ZCX6 20240621 700
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved